ESSA Pharma Inc.
EPIX
$0.2456
-$0.0175-6.65%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 39.29% | -7.45% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -33.66% | -23.78% | |||
| Operating Income | 33.66% | 23.78% | |||
| Income Before Tax | 37.20% | 25.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 37.20% | 25.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 37.20% | 25.28% | |||
| EBIT | 33.66% | 23.78% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 37.19% | 25.29% | |||
| Normalized Basic EPS | 39.53% | 25.23% | |||
| EPS Diluted | 37.19% | 25.29% | |||
| Normalized Diluted EPS | 39.53% | 25.23% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||